Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 1,852 | 1,310 | 1,503 | 1,489 | 1,366 |
| Cost of Goods | 1,113 | 786 | 910 | 957 | 868 |
| Gross Profit | 740 | 524 | 594 | 532 | 498 |
| Operating Expenses | 5,517 | 4,827 | 4,705 | 5,198 | 4,404 |
| Operating Income | -4,664 | -3,517 | -3,202 | -3,709 | -3,038 |
| Interest Expense | 449 | 453 | 476 | 381 | 335 |
| Other Income | 11 | -709 | 73 | -25 | -11 |
| Pre-tax Income | -5,102 | -4,679 | -3,606 | -4,115 | -3,385 |
| Net Income Continuous | -5,102 | -4,679 | -3,606 | -3,563 | -3,385 |
| Net Income | $-5,102 | $-4,679 | $-3,606 | $-3,563 | $-3,385 |
| EPS Basic Total Ops | -0.48 | -0.44 | -0.37 | -0.38 | -0.36 |
| EPS Basic Continuous Ops | -0.48 | -0.44 | -0.37 | -0.38 | -0.36 |
| EPS Diluted Total Ops | -0.48 | -0.44 | -0.37 | -0.38 | -0.36 |
| EPS Diluted Continuous Ops | -0.48 | -0.44 | -0.37 | -0.38 | -0.36 |
| EBITDA(a) | $-4,450 | $-3,353 | $-3,035 | $-3,561 | $-2,936 |